FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11505811000001103: Tiabendazole 500mg chewable tablets 36 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42267601000001118 Tiabendazole 500mg chewable tablets 36 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42267701000001111 Tiabendazole 500mg chewable tablets 36 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tiabendazole 500mg chewable tablets 36 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Is pack of Product containing precisely tiabendazole 500 milligram/1 each conventional release chewable tablet false Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Has active ingredient Tiabendazole false Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Has VMP Product containing precisely tiabendazole 500 milligram/1 each conventional release chewable tablet true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Has specific active ingredient Tiabendazole true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Tiabendazole 500mg chewable tablets 36 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mintezol 500mg chewable tablets (Merck & Co. Inc) 36 tablet Is a True Tiabendazole 500mg chewable tablets 36 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start